Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis

Background: Insulin secretory agents are commonly used to treat type 2 diabetes. However, traditional insulin secretory agents such as sulfonylureas and glinides have side effects of hypoglycemia. In recent years, researchers have discovered that berberine can inhibit the voltage-gated k(+) channels...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Wenting, Su, Fugui, Wang, Guizhong, Peng, Zichong, Xu, Yaomin, Zhang, Yi, Xu, Ningning, Hou, Kaijian, Hu, Zhuping, Chen, Yan, Chen, Rongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709280/
https://www.ncbi.nlm.nih.gov/pubmed/36467075
http://dx.doi.org/10.3389/fphar.2022.1015045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709280/
https://www.ncbi.nlm.nih.gov/pubmed/36467075
http://dx.doi.org/10.3389/fphar.2022.1015045

Ejemplares similares